Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Queisser, M. Wygrecka, U. Schubert, M. Koenigshoff, F. Kouri, K. Kitowska, O. Eickelberg, K. Preissner (Giessen, Germany). Loss of receptor for advanced glycation end products (RAGE) in idiopathic pulmonary fibrosis. Eur Respir J 2007; 30: Suppl. 51, 1843

Member's Comments

No comment yet.

Related content which might interest you: Reduced soluble receptor for advanced glycation end-products in COPD Source: Eur Respir J 2011; 37: 516-522 Year: 2011 Advanced glycation end products and its soluble receptor (sRAGE) are increased in chronic heart failure but not in chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 Soluble receptor for advanced glycation end products (sRAGE) in asthmatic children as a new marker of the disease control Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021 Soluble RAGE is deficient in neutrophilic asthma and COPD Source: Eur Respir J 2012; 39: 721-729 Year: 2012 Advanced glycation end product (AGE), soluble receptor for AGE (sRAGE) and inflammation in smokers and mild/moderate chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Year: 2015 Advanced glycation endproducts are increased in lung tissue from patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 A role of the advanced glycation end products (AGEs) in epithelial-myofibroblast transition Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Importance of the receptor for advanced glycation end products in the respiratory mechanics Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012 Decreased circulatory receptor for advanced glycation end-products is associated with poorer survival in patients with idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 1 Year: 2014 Late Breaking Abstract - Increased advanced glycation end-products (AGEs) accumulation in skin is a risk factor lung function deterioration in asthmatic patients- preliminary data Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Signalling through the receptor for advanced glycation end products (RAGE) is increased in acute asthma and correlates with symptom severity Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Increased expression of receptor for advanced glycation end products in COPD Source: International Congress 2014 – Translational studies in COPD Year: 2014 Measures of lung function and their relationship with advanced glycation end-products Source: ERJ Open Res, 6 (2) 00356-2019; 10.1183/23120541.00356-2019 Year: 2020 Receptor for advanced glycation end products (RAGE) is involved in cigarette smoke induced inflammation and emphysema Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Plasma advanced glycation end-products and skin autofluorescence are increased in COPD Source: Eur Respir J 2014; 43: 430-438 Year: 2013 Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review Source: Eur Respir Rev, 28 (151) 180096; 10.1183/16000617.0096-2018 Year: 2019 Advanced glycation endproducts (AGE) contribute to the expression of pro-fibrotic cytokines and collagen production in a cell type dependent manner Source: Eur Respir J 2006; 28: Suppl. 50, 823s Year: 2006 Anti-tumorigenic effect of age-/diabetes-related advanced glycation end-products in lung carcinoma Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 RAGE and sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 346s Year: 2005